Key Takeaways
- • Even Healthcare secures Rs 208.24 crore ($22 million) in Series B funding led by Khosla Ventures, which commits Rs 145 crore as the primary investor, valuing the company at approximately $300 million post-round.
- • Syndicate participation includes DLB Ventures (Rs 38.88 crore), Simon Fiduciaria (Rs 22.67 crore), ADBEEV LLP, and Better Capital, demonstrating institutional conviction in the membership-based healthcare model.
- • Even Healthcare operates a differentiated primary care model featuring membership-based access to diagnostics, hospital services, and continuous care coordination across consultation, hospitalization, and post-discharge phases rather than transactional healthcare relationships.
- • Financial trajectory shows revenue growth of 4x year-over-year to Rs 25.43 crore in FY25, though losses widened to Rs 90.15 crore, indicating scaling phase dynamics typical of early-stage health tech platforms.
- • This represents Even's second funding round in 2026, following a $20 million Series A-equivalent raise in January led by Lachy Groom and Alpha Wave, signaling accelerated capital deployment and market validation.
Summary
Even Healthcare has closed a Series B funding round of Rs 208.24 crore (approximately $22 million USD), with Khosla Ventures leading the investment through a Rs 145 crore commitment. The round values the company at approximately $300 million post-money, according to regulatory filings and multiple news sources. Co-investors include DLB Ventures (Rs 38.88 crore), Simon Fiduciaria (Rs 22.67 crore), with additional participation from ADBEEV LLP and Better Capital, reflecting broad institutional backing for the platform's expansion strategy.
Founded in 2020, Even Healthcare operates a membership-based healthcare delivery model that differentiates itself through continuous care coordination rather than episodic transactions. The platform provides primary care, diagnostics, and hospital services while maintaining care team relationships across consultations, hospitalization, and post-discharge recovery phases. This continuity-of-care approach represents a structural departure from traditional fee-for-service healthcare models, positioning Even within the broader digital health infrastructure trend gaining traction in India's healthcare ecosystem.
The Series B round represents Even's second major capital infusion in 2026, following a $20 million fundraise in January led by investor Lachy Groom and Alpha Wave. This accelerated pace of capital deployment within a single fiscal year underscores investor confidence and the company's scaling requirements. Even demonstrated meaningful financial progress in FY25, reporting Rs 25.43 crore in revenue—representing four-fold year-over-year growth—though operational losses expanded to Rs 90.15 crore, consistent with growth-stage healthcare platforms investing heavily in market expansion and care infrastructure.
The timing of the Series B funding precedes the company's FY26 financial filings, positioning this capital round as a critical milestone for evaluating operational efficiency improvements and unit economics as Even scales its membership-based model across markets. For institutional investors tracking digital health and healthcare delivery innovation in emerging markets, Even's funding trajectory and revenue growth rate warrant close monitoring as membership-based primary care models gain adoption in India's fragmented healthcare delivery landscape.
Founded in 2020, Even Healthcare operates a membership-based healthcare delivery model that differentiates itself through continuous care coordination rather than episodic transactions. The platform provides primary care, diagnostics, and hospital services while maintaining care team relationships across consultations, hospitalization, and post-discharge recovery phases. This continuity-of-care approach represents a structural departure from traditional fee-for-service healthcare models, positioning Even within the broader digital health infrastructure trend gaining traction in India's healthcare ecosystem.
The Series B round represents Even's second major capital infusion in 2026, following a $20 million fundraise in January led by investor Lachy Groom and Alpha Wave. This accelerated pace of capital deployment within a single fiscal year underscores investor confidence and the company's scaling requirements. Even demonstrated meaningful financial progress in FY25, reporting Rs 25.43 crore in revenue—representing four-fold year-over-year growth—though operational losses expanded to Rs 90.15 crore, consistent with growth-stage healthcare platforms investing heavily in market expansion and care infrastructure.
The timing of the Series B funding precedes the company's FY26 financial filings, positioning this capital round as a critical milestone for evaluating operational efficiency improvements and unit economics as Even scales its membership-based model across markets. For institutional investors tracking digital health and healthcare delivery innovation in emerging markets, Even's funding trajectory and revenue growth rate warrant close monitoring as membership-based primary care models gain adoption in India's fragmented healthcare delivery landscape.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.